跳至主要内容
临床试验/JPRN-UMIN000007624
JPRN-UMIN000007624已完成未知

Piolt study of usefulness of analysis of genetic polymorphism of aldehyde dehydrogenase 2 (ALDH2) in safety of paclitaxel for the patients with alcohol intolerance - Role of genetic polymorphism of aldehyde dehydrogenase 2 (ALDH2) in the alcohol-related toxicity of paclitaxel

Osaka International Cancer Institute0 个研究点目标入组 20 人开始时间: 2012年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Pregnancy, the possibility of pregnancy or breast feeding. 2)Patients unable to take paclitaxcel because of significant cardiovascular abnormalities, renal dysfunction, hepatic insufficiency, uncontrolled hypertension, uncontrolled diabetes, bleeding tendency, active interstitial pneumonia ,etc. 3)Febrile patients who are suspected to be infected. 4)Prior treatment with paclitaxcel 5)Patients unable to comply with the protocol, in the opinion of the investigator. 6)Other contraindication to paclitaxcel. (1)severe myelosuppression (2)Known hypersensitivity to paclitaxcel or drugs which contain polyoxyethylene caster oil (e.g. ciclosporin injection). (3) Patient taking disulfiram, cyanamide, carmofur, and procarbazine hydrochloride.

研究者

相似试验

Piolt study of usefulness of analysis of genetic... | 临床试验